These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28233606)

  • 1. Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives.
    Mayer T; Meid AD; Saum KU; Brenner H; Schöttker B; Seidling HM; Haefeli WE
    Am J Geriatr Psychiatry; 2017 May; 25(5):531-540. PubMed ID: 28233606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
    De Vreese LP; Mantesso U; De Bastiani E; Marangoni A; Weger E; Gomiero T
    PLoS One; 2018; 13(10):e0205897. PubMed ID: 30379948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
    Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
    Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?
    Mayer T; Haefeli WE; Seidling HM
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1299-314. PubMed ID: 26350641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients.
    Lavrador M; Cabral AC; Figueiredo IV; Veríssimo MT; Castel-Branco MM; Fernandez-Llimos F
    Int J Clin Pharm; 2021 Feb; 43(1):128-136. PubMed ID: 32860598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.
    Salahudeen MS; Hilmer SN; Nishtala PS
    J Am Geriatr Soc; 2015 Jan; 63(1):85-90. PubMed ID: 25597560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
    Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
    Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
    Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
    J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
    Ruxton K; Woodman RJ; Mangoni AA
    Br J Clin Pharmacol; 2015 Aug; 80(2):209-20. PubMed ID: 25735839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
    Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
    J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home.
    Landi F; Dell'Aquila G; Collamati A; Martone AM; Zuliani G; Gasperini B; Eusebi P; Lattanzio F; Cherubini A
    J Am Med Dir Assoc; 2014; 15(11):825-9. PubMed ID: 25282629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study.
    Lechevallier-Michel N; Molimard M; Dartigues JF; Fabrigoule C; Fourrier-Réglat A
    Br J Clin Pharmacol; 2005 Feb; 59(2):143-51. PubMed ID: 15676035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anticholinergic burden of medications in older adults.
    West T; Pruchnicki MC; Porter K; Emptage R
    J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.
    Crispo JA; Willis AW; Thibault DP; Fortin Y; Hays HD; McNair DS; Bjerre LM; Kohen DE; Perez-Lloret S; Mattison DR; Krewski D
    PLoS One; 2016; 11(3):e0150621. PubMed ID: 26939130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
    Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
    Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.